🔎 Trials Near Me

Home › Lymphoma › New Jersey › Edison

Pag-aaral pangklinika para sa Lymphoma sa Edison, NJ

Isang pag-aaral para sa Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Edison. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Rutgers University Study of the Genetics of Blood Cancers

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • Rutgers University, Piscataway · 2 mi ang layo
Edad 18 hanggang 110 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07714044

Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

Nagre-recruitPhase 2
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT02974647

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

Nagre-recruitPhase 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07015242

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

Nagre-recruitPhase 1
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT04301076

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

Nagre-recruitPhase 3
  • Research Site, Basking Ridge · 15 mi ang layo
Edad 18 hanggang 18 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07509151

A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

Nagre-recruitPhase 3
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06084936

A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

Nagre-recruitPhase 2
  • Memorial Sloan Kettering at Basking Ridge Limited Protocol Activities, Basking Ridge · 15 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT05389293

A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)

Nagre-recruitPhase 1
  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 5, 2026 · NCT07137494

A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
  • Memorial Sloan Kettering Basking Ridge (All protocol activities), Basking Ridge · 15 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update May 26, 2026 · NCT07052916

A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1

Nagre-recruitPhase 2
  • Memorial Sloan Kettering at Basking Ridge (All protocol activities), Basking Ridge · 15 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 5, 2026 · NCT06698003

Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma

Nagre-recruitObservasyonal na pag-aaral
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi ang layo
Edad 18 pataas · Kababaihan · Na-update Mar 4, 2026 · NCT01788839

Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi ang layo
Lahat ng edad · Lahat ng kasarian · Na-update Ene 23, 2026 · NCT00582621

Pag-aaral para sa Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Edison

Mula sa ClinicalTrials.gov, na-kuha noong Set 29, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.